A detailed history of Cypress Capital Management LLC (Wy) transactions in Amgen Inc stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 4,218 shares of AMGN stock, worth $1.11 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
4,218
Previous 4,286 1.59%
Holding current value
$1.11 Million
Previous $1.34 Million 1.49%
% of portfolio
1.48%
Previous 1.43%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $21,037 - $22,941
-68 Reduced 1.59%
4,218 $1.36 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $75,409 - $91,641
-287 Reduced 6.28%
4,286 $1.34 Million
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $6,452 - $7,789
-24 Reduced 0.52%
4,573 $1.3 Million
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $61,879 - $69,807
-242 Reduced 5.0%
4,597 $1.32 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $21,646 - $26,874
-99 Reduced 2.0%
4,839 $1.3 Million
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $29,997 - $35,471
-140 Reduced 2.76%
4,938 $1.1 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $2,483 - $3,027
-11 Reduced 0.22%
5,078 $1.23 Million
Q4 2022

Feb 02, 2023

BUY
$229.03 - $291.01 $1.15 Million - $1.47 Million
5,037 Added 9686.54%
5,089 $1.34 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $11,402 - $12,613
52 New
52 $13,000
Q1 2019

May 06, 2019

SELL
$180.87 - $203.88 $42,685 - $48,115
-236 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $14,272 - $16,660
-80 Reduced 25.32%
236 $46,000
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $30,055 - $33,758
181 Added 134.07%
316 $58,000
Q4 2017

Jan 31, 2018

BUY
$168.79 - $188.59 $13,503 - $15,087
80 Added 145.45%
135 $23,000
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $9,200 - $10,505
55
55 $10,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.